Receptor | Dopamine | Norepinephrine | NE/DA (EC50) | ||
---|---|---|---|---|---|
EC50 (nM) | Emax | EC50 (nM) | Emax | ||
D2LR | 96 ± 16 | 11 ± 1 | 4800 ± 1720 | 11 ± 2 | 50 |
D2SR | 105 ± 21 | 18 ± 2a | 2880 ± 1150 | 17 ± 2 | 27.4 |
D3R | 3 ± 1b | 15 ± 2c | 32 ± 5c | 13 ± 2 | 10.7 |
D4.2R | 38 ± 13c | 9 ± 1 | 3750 ± 1620 | 10 ± 2 | 100 |
D4.4R | 66 ± 13 | 8 ± 1 | 2830 ± 666 | 7 ± 1 | 43 |
D4.7R | 44 ± 12c | 9 ± 1 | 1840 ± 889 | 8 ± 2 | 41.8 |
NE/DA, ratio between EC50 values of norepinephrine and dopamine for each receptor.
↵a P < 0.01, compared with D2LR (one-way analysis of variance, followed by post hoc Newman-Keuls test).
↵b P < 0.001, compared with D2LR (one-way analysis of variance, followed by post hoc Newman-Keuls test).
↵c P < 0.05, compared with D2LR (one-way analysis of variance, followed by post hoc Newman-Keuls test).